Menu

HHMI Competition Opens

The biomedical institute seeks up to 30 new investigators in its first nationwide search in 5 years.

Mar 16, 2012
Megan Scudellari

UC DAVIS COLLEGE OF ENGINEERING, WIKIMEDIA COMMONS

Yesterday (March 15), the Howard Hughes Medical Institute, a national nonprofit medical research organization, opened a national competition for new investigators. The institute will invest some $200 million in up to 30 new biomedical researchers, “among the most creative and promising in the nation,” according to the organization’s website. The last competition was held in 2007.

The Institute’s approximately 340 Hughes investigators currently include 13 Nobel Prize winners and 147 members of the National Academy of Sciences. The Institute spent $825 million for research in fiscal year 2011.

The 2012 competition is open to scientists in all biomedical disciplines, as well as researchers from other fields such as biophysics, biomedical engineering, and evolutionary biology. Each winner will receive a 5-year appointment as an HHMI investigator and substantial funding to explore new research ideas and even change research directions.

“We’re betting on the individual, not necessarily on the specific research that they’re conducting today,” said Jack E. Dixon, HHMI vice president and chief scientific officer, said in a press release.

Candidates apply directly to HHMI, and applications must be received by June 13. Eligibility and application information can be found here. Finalists will be announced in the spring of 2013 with appointments as early as September 1, 2013.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!